These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31037448)

  • 1. Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.
    Sugawara K; Koizumi S; Horikawa Y; Mimori N; Tsuji T; Ishii H; Fujimori S; Onochi K; Watanabe H; Iijima K
    J Gastroenterol; 2019 Nov; 54(11):963-971. PubMed ID: 31037448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of Helicobacter pylori in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials.
    Hou X; Wang J; Du Q; Tian D; Hu N; Liu D; Zhou F; Xie L; Gu L; Kudou K; Zhang S
    Biol Pharm Bull; 2024; 47(8):1405-1414. PubMed ID: 39085080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan.
    Kanno T; Iijima K; Abe Y; Yagi M; Asonuma S; Ohyauchi M; Ito H; Koike T; Shimosegawa T
    J Gastroenterol Hepatol; 2015 May; 30(5):842-8. PubMed ID: 25532720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
    Arkkila PE; Seppälä K; Kosunen TU; Sipponen P; Mäkinen J; Rautelin H; Färkkilä M
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):93-101. PubMed ID: 15647648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential location of idiopathic peptic ulcers.
    Iijima K; Kanno T; Abe Y; Yagi M; Asonuma S; Ohyauchi M; Ito H; Koike T; Shimosegawa T
    Scand J Gastroenterol; 2016 Jul; 51(7):782-7. PubMed ID: 26854021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vonoprazan vs. Proton Pump Inhibitors for Treatment and Prevention of Gastric and/or Duodenal Ulcers: A Systematic Review with Meta-Analysis.
    Simadibrata DM; Lesmana E; Pratama MIA; Sugiharta AJ; Kalaij AGI; Fadhilla ADD; Danpanichkul P; Syam AF; Simadibrata M
    Dig Dis Sci; 2024 Oct; 69(10):3863-3874. PubMed ID: 39294424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study: Vonoprazan and proton pump inhibitors in
    Sakurai K; Suda H; Ido Y; Takeichi T; Okuda A; Hasuda K; Hattori M
    World J Gastroenterol; 2017 Jan; 23(4):668-675. PubMed ID: 28216974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori-negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence: Multicenter follow-up study of peptic ulcers in Japan.
    Kanno T; Iijima K; Abe Y; Yagi M; Asonuma S; Ohyauchi M; Ito H; Koike T; Shimosegawa T
    Dig Endosc; 2016 Jul; 28(5):556-63. PubMed ID: 26866510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
    Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
    J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Vonoprazan for Helicobacter pylori Eradication.
    Kiyotoki S; Nishikawa J; Sakaida I
    Intern Med; 2020 Jan; 59(2):153-161. PubMed ID: 31243237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
    Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
    Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and effectiveness of vonoprazan-based
    Ashida K; Honda Y; Sanada K; Takemura Y; Sakamoto S
    Expert Opin Drug Saf; 2019 Dec; 18(12):1255-1261. PubMed ID: 31646920
    [No Abstract]   [Full Text] [Related]  

  • 15. Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Mochizuki S; Matsuo K; Isomura Y; Seto M; Suzuki N; Suzuki H; Yamamoto S; Sugimoto T; Omae T; Okamoto M; Watabe H; Togo G; Takano N; Fukui K; Ito Y; Koike K
    J Dig Dis; 2016 Oct; 17(10):670-675. PubMed ID: 27534444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT; Genta RM; Karttunen TJ; Graham DY
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.
    Yang X; Li Y; Sun Y; Zhang M; Guo C; Mirza IA; Li YQ
    Dig Dis Sci; 2018 Feb; 63(2):302-311. PubMed ID: 29282636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease.
    Xia HH; Phung N; Kalantar JS; Talley NJ
    Med J Aust; 2000 Nov; 173(10):515-9. PubMed ID: 11194733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
    Hou X; Meng F; Wang J; Sha W; Chiu CT; Chung WC; Gu L; Kudou K; Chong CF; Zhang S
    J Gastroenterol Hepatol; 2022 Jul; 37(7):1275-1283. PubMed ID: 35342997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic approaches to gastric and duodenal ulcers: an update.
    Dajani EZ; Klamut MJ
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1537-44. PubMed ID: 11060758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.